Lang, W., Wang, J., Ouyang, M., Zhao, H., Zhou, T., Huang, L. (2025). Cost-effectiveness analysis of benmelstobart and anlotinib plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: Perspectives from the United States and China. PLoS ONE. https://doi.org/10.1371/journal.pone.0331338